ECSIT promotes NFκB activity (Wi et al., 2014), and in AD experimental models, repression of NFκB activity decreases BACE1 activity and both soluble and insoluble Aβ (Paris et al., 2010). The gene discussed is BACE1; the disease is Alzheimer disease.